|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.00 CHF | -2.65% |
|
-1.17% | -4.01% |
Business description: DSM-Firmenich
Number of employees: 26,873
Sales by Activity: DSM-Firmenich
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Perfumery & Beauty | - | - | 2.62B | 3.96B | 3.76B |
Taste, Texture & Health | - | - | 2.47B | 3.24B | 3.15B |
Health Nutrition & Care | - | 2.94B | 2.25B | 2.21B | 2.1B |
Nutrition | 7.08B | - | - | - | - |
Corporate Activities | 70M | 71M | 68M | 52M | 26M |
Food & Beverages | - | 1.55B | - | - | - |
Eliminations | -76M | - | - | - | - |
Animal Nutrition & Health | - | 3.79B | 3.22B | 3.32B | - |
Innovation Center | 186M | - | - | - | - |
Materials | 1.95B | - | - | - | - |
Other Activities | - | 46M | - | - | - |
Geographical breakdown of sales: DSM-Firmenich
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Rest of EMEA | - | - | 3.1B | 3.94B | 3.1B |
North America | 1.31B | 1.87B | 2.42B | 2.93B | 2.35B |
Rest of Asia | 387M | 1.19B | 1.83B | 2.32B | 1.54B |
Latin America | 666M | 1.51B | 1.65B | 1.89B | 857M |
China | 1.18B | 803M | 997M | 1.1B | 671M |
Netherlands | 1.86B | 402M | 424M | 420M | 302M |
Switzerland | 2.37B | 156M | 204M | 214M | 214M |
Rest of Europe | 1.34B | 2.15B | - | - | - |
Rest of the World | 98M | 311M | - | - | - |
Executive Committee: DSM-Firmenich
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 31/12/2019 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 31/08/2023 |
| Compliance Officer | 55 | 30/04/2025 | |
Ipek Ozsuer
CTO | Chief Tech/Sci/R&D Officer | 46 | 30/04/2023 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/12/2022 |
Composition of the Board of Directors: DSM-Firmenich
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Leysen
CHM | Chairman | 65 | 31/01/2023 |
| Director/Board Member | 64 | 31/01/2023 | |
André Pometta
BRD | Director/Board Member | 61 | 31/01/2023 |
| Director/Board Member | 66 | 31/01/2023 | |
| Director/Board Member | 67 | 31/01/2023 | |
| Director/Board Member | 61 | 31/01/2023 | |
Erica Mann
BRD | Director/Board Member | 67 | 30/04/2019 |
| Director/Board Member | 65 | 31/01/2023 | |
John Ramsay
BRD | Director/Board Member | 68 | 31/01/2023 |
Richard Ridinger
BRD | Director/Board Member | 68 | 31/01/2023 |
Company details: DSM-Firmenich
Group companies: DSM-Firmenich
| Name | Category and Sector |
|---|---|
Chemicals: Major Diversified
| |
Firmenich International SA
 Firmenich International SA Household/Personal CareConsumer Non-Durables Operates as fragrance & flavor company |
Household/Personal Care
|
DSM Nutritional Products AG
 DSM Nutritional Products AG Household/Personal CareConsumer Non-Durables Manufactures perfumes, health and animal nutrition products |
Household/Personal Care
|
Firmenich et CIE SAS
 Firmenich et CIE SAS Chemicals: SpecialtyProcess Industries Manufactures industrial organic chemicals |
Chemicals: Specialty
|
PT Firmenich Aromatics Indonesia
 PT Firmenich Aromatics Indonesia Food: Specialty/CandyConsumer Non-Durables Manufactures and wholesales additives, flavorings and yeast |
Food: Specialty/Candy
|
Consumer Goods Conglomerates
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.65% | -1.17% | -32.07% | -43.10% | 19.14B | |
| -0.46% | +0.90% | -6.08% | +45.16% | 1,041B | |
| 0.00% | 0.00% | -2.74% | -1.29% | 232B | |
| +3.02% | -2.55% | +26.10% | +197.88% | 136B | |
| -1.52% | +0.06% | -4.33% | +11.29% | 135B | |
| -1.97% | -9.53% | +44.17% | +649.45% | 86.4B | |
| -0.31% | -0.68% | +118.60% | +271.08% | 82.74B | |
| +0.76% | +2.04% | -4.50% | +49.19% | 76.26B | |
| -1.23% | -2.78% | -1.46% | +9.59% | 71.26B | |
| +1.47% | +2.72% | +56.65% | +44.45% | 21.44B | |
| Average | -0.29% | -0.73% | +19.44% | +123.37% | 190.12B | |
| Weighted average by Cap. | -0.27% | +0.22% | +5.15% | +83.26% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DSFIR Stock
- Company DSM-Firmenich
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition